Decade of Vaccine Economics IV (DOVE-IV)

Challenge

While vaccines are regarded as one of the most cost-effective public health interventions, substantial gaps still exist in the evidence base on their broader economic impact, including cost of illness averted.

Approach

The Decade of Vaccine Economics (DOVE) IV generates evidence on the economic impact of vaccination by building upon previously developed DOVE models and gathering primary data on the cost of illness averted due to vaccine preventable diseases in two low- or middle-income countries. The modeling component of this project aims to assess the progress of vaccination efforts since the creation of Gavi (2001), through the Decade of Vaccines (2011-2020) and beyond in reaching the goals set forth in the Global Vaccine Action Plan to inform vaccine priorities and policies. The data collection component will address the need for country-level cost of illness data for vaccine-preventable diseases by developing and testing a standard protocol for collecting this information.

Results

Major deliverables of the DOVE IV project include a protocol for cost of illness data collection, primary data on cost of illness from two countries, updating and extending existing DOVE models (cost of illness, DALY (disability adjusted life years), and value of life year), and collaborating with other research institutions to supplement economic benefits estimates, a database of updated economic impact estimates, reports/scientific publications, and dissemination of research outputs. Field studies concluding in May (Bangladesh) and August (Uganda) 2018. Model updates concluding Q1 2019.

For more information, subscribe to the DOVE IV monthly newsletter here. The newsletter shares insightful learning modules on health economics, most current progress updates, challenges found in fieldwork, and some preliminary results on COI in Uganda.

Op-Eds and Other Media Publications
  1. Constenla D, Ekirapa EK, De Broucker G. DOVE-IV: Measuring the Cost of Illness. March 2018. Access at: http://immunizationeconomics.org/recent-activity/2018/3/30/engaging-local-stakeholders-in-economic-evaluation
  2. Constenla D, Uddin J. Measuring the Cost of Childhood Diseases – Laying the Groundwork for Countries in Asia to Establish a Viable Plan for Standardized Data Collection, Data Entry and Data Monitoring Procedures. Global Immunization Newsletter. September 2017. Access at: http://www.who.int/immunization/gin/en/
  3. Constenla D, Uddin J. Measuring the Cost of Childhood Diseases – Laying the Groundwork for Countries in Asia to Establish a Viable Plan for Standardized Data Collection, Data Entry and Data Monitoring Procedures. Global Immunization Newsletter. September 2017. Access at: http://www.who.int/immunization/gin/en/